Population-level trends in hepatocellular carcinoma incidence, treatment and mortality in Queensland, according to socio demographic factors and geographic location, with case record linkage to viral hepatitis notifications, 1996 - 2010.

昆士兰州肝细胞癌发病率、治疗和死亡率的人口水平趋势，根据社会人口因素和地理位置，以及病例记录与病毒性肝炎通知的联系，1996年至2010年。

• 批准号: nhmrc : 1052622
• 负责人: Dr Paul Clark
• 金额: $ 17.57万
• 依托单位: Queensland Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/population-level-trends-1996-2010/112289
• 关键词: Population; level; trends; hepatocellular; carcinoma

Incidence and mortality of hepatocellular carcinoma (HCC, the most common form of liver cancer) is increasing in Australia, driven by viral hepatitis infections. Disease burden is not defined in Queensland, particularly for Indigenous, migrant and regional and remote communities. Such factors may influence risk of viral hepatitis, access to treatment, and incidence and survival of HCC. Defining disease burdens will enable clinical programs targeted at groups most at risk in order to impact HCC trends.

肝细胞癌（HCC，最常见的肝癌形式）的发病率和死亡率在澳大利亚不断增加，这是由病毒性肝炎感染引起的。昆士兰州没有界定疾病负担，特别是土著、移民和区域及偏远社区。这些因素可能会影响病毒性肝炎的风险，获得治疗，以及HCC的发病率和生存率。定义疾病负担将使临床项目能够针对风险最高的群体，以影响HCC趋势。